×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| ANUH PHARMA LTD. | 1,995.38 | 124.57 | 1,981.40 | 2.49 | 977.0 | 20.6 |
| Sastasundar Ventures Limited | 3074.68 | 175.72 | 2858.41 | 4.3 | 926 | 25.6 |
| Shukra Pharmaceuticals Limited | 147.35 | 53.87 | 132.70 | 0.12 | 889 | 92.8 |
Anuh Pharma Ltd.,, with Security Code 506260, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 138.7 | 157.3 | 161.5 | 149.5 | 172.1 | 163.9 | 137.9 | 166.0 | 159.5 | 198.1 |
| Expenses | 126.3 | 143.1 | 147.5 | 131.6 | 148.1 | 144.7 | 127.3 | 149.1 | 144.7 | 179.4 |
| Operating Profit | 12.4 | 14.2 | 14.0 | 18.0 | 24.0 | 19.2 | 10.6 | 16.9 | 14.8 | 18.7 |
| OPM % | 8.96% | 9.05% | 8.65% | 12.01% | 13.94% | 11.73% | 7.66% | 10.17% | 9.27% | 9.45% |
| Other Income | 2.1 | 1.0 | 3.5 | 2.1 | 3.7 | 2.8 | 3.7 | 3.4 | 0.9 | 1.4 |
| Interest | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.0 |
| Depreciation | 2.4 | 2.4 | 2.0 | 2.1 | 2.2 | 2.2 | 1.9 | 1.9 | 2.2 | 2.8 |
| Profit before tax | 12.1 | 12.8 | 15.4 | 17.9 | 25.3 | 19.7 | 12.3 | 18.2 | 13.3 | 17.3 |
| Tax % | -23% | -25.1% | -23.8% | -22.6% | -24.5% | -22.1% | -22.5% | -17.3% | 22% | -27.8% |
| Net Profit | 9.3 | 9.6 | 11.8 | 13.8 | 19.1 | 15.4 | 9.5 | 15.0 | 10.3 | 12.5 |
| EPS in Rs | 0.93 | 0.96 | 1.18 | 1.38 | 1.91 | 1.53 | 0.95 | 1.5 | 1.03 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 19% |
| 3 Years: | 32% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 22% |
| 3 Years: | 30% |
| 1 Year: | -8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|